Cellares

Stub active Updated Jun 11, 2026

This profile is AI-generated. If you spot an error, please help us fix it by sharing a URL to the correct information.

Location Burlingame, California
Founded 2019
Latest Stage Series D
Total Raised ~$632M
Website https://cellares.com
Sector
biotech healthcare cell-therapy manufacturing

Investors

Byron Knight (board seat) (2022)
New Enterprise Associates (NEA) series-d (2026)
Koch Disruptive Technologies (board seat) (2022)

About

Cellares is a Burlingame, California-based biotech company that develops automated “Cell Manufacturing Centers” for producing CAR-T and engineered cell therapies 1. The company aims to address manufacturing bottlenecks in personalized medicine, with total funding reaching approximately $632M following its Series D 1.

Funding History

Date Round Amount Lead Co-investors
2026-06-10 Series D $277M ARK Invest, NEA, RA Capital Janus Henderson, Redmile, Andera Partners, BroadOak Capital 1

What Investors Say

No independently sourced investor quotes found at time of publication.

What Founders Say

No independently sourced founder testimonials found at time of publication.

Sources

  1. TechStartups, “Venture Capital & Startup Funding Roundup, June 10, 2026.” Accessed June 2026. https://techstartups.com/2026/06/10/venture-capital-startup-funding-roundup-june-102026/↩↩↩